Treatment of Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia.

Abstract

Opinion statementOver the past 15 years, the landscape of Ph+ ALL has changed dramatically. No longer the most dreaded form of acute leukemia, the advent of tyrosine kinase inhibitors (TKIs) has ushered in a new era, as TKIs have become the backbone of any treatment regimen for Ph+ ALL. A greater number achieve a complete remission allowing for more… (More)
DOI: 10.1007/s11864-017-0455-3

Topics

  • Presentations referencing similar topics